![](/img/cover-not-exists.png)
P72 ORAL TREATMENT WITH PBI-4050, A NOVEL FIRST-IN-CLASS ANTI-FIBROTIC COMPOUND, REDUCES HEPATIC FIBROSIS AND HEPATOCELLULAR CARCINOMA
Gagnon, L., Geerts, L., Doucet, A., Sarra-Bournet, F., Tremblay, M., Hince, K., Abbott, S., Duceppe, J.-S., Zacharie, B., Penney, C., Laurin, P., Grouix, B.Volume:
60
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(14)60235-X
Date:
April, 2014
File:
PDF, 60 KB
english, 2014